cellvie secures $5 Million in fresh capital from existing and new investors
/
DateSep 09 2025
Zurich, Switzerland – September 9th, 2025 – cellvie, a company pioneering therapeutics based on mitochondria, today announced the closing of a $5 million funding round,... Read More →
















